ENBOMAY Trademark
Trademark Overview
On Monday, April 7, 2025, a trademark application was filed for ENBOMAY with the United States Patent and Trademark Office. The USPTO has given the ENBOMAY trademark a serial number of 99123433. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Wednesday, July 16, 2025. This trademark is owned by Merck Sharp & Dohme B.V.. The ENBOMAY trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations
General Information
| Serial Number | 99123433 |
| Word Mark | ENBOMAY |
| Filing Date | Monday, April 7, 2025 |
| Status | 680 - APPROVED FOR PUBLICATION |
| Status Date | Wednesday, July 16, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, April 7, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Merck Sharp & Dohme B.V. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 26 - NOT AVAILABLE |
| Address | HAARLEM 2031BN
NL |
Trademark Events
| Event Date | Event Description |
| Monday, April 7, 2025 | NEW APPLICATION ENTERED |
| Monday, April 7, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, April 7, 2025 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, June 25, 2025 | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED |
| Wednesday, July 16, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, July 14, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, June 25, 2025 | TEAS VOLUNTARY AMENDMENT RECEIVED |
